Bristol Myers Squibb reports results from Phase II study of BMS-986278

Bristol Myers Squibb reports results from Phase II study of BMS-986278

Submitted by admin on September 11, 2023 - 11:53am
Source: 
Clinical Trials Arena
News Tags: 
Bristol Myers Squibb
clinical trials
progressive pulmonary fibrosis
BMS-986278
Headline: 
Bristol Myers Squibb reports results from Phase II study of BMS-986278
snippet: 

Bristol Myers Squibb has reported results from a Phase II study of BMS-986278 for the treatment of progressive pulmonary fibrosis (PPF).

Do Not Allow Advertisers to Use My Personal information